Overview A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes Status: Completed Trial end date: 2001-05-03 Target enrollment: Participant gender: Summary This trial is conducted in Europe. A seven day dose escalation study in subjects with type 2 diabetes. Phase: Phase 1 Details Lead Sponsor: Novo Nordisk A/S